Skip to main content
Erschienen in: Neuroradiology 11/2010

01.11.2010 | Diagnostic Neuroradiology

Does registration of serial MRI improve diagnosis of dementia?

verfasst von: Josephine Barnes, L. Anne Mitchell, Jonathan Kennedy, Antonio J. Bastos-Leite, Suzie Barker, Manja Lehmann, R. Chris Nordstrom, Chris Frost, Joseph R. Smith, Ellen Garde, Martin N. Rossor, Nick C. Fox

Erschienen in: Neuroradiology | Ausgabe 11/2010

Einloggen, um Zugang zu erhalten

Abstract

Introduction

We aimed to assess the value of a second MR scan in the radiological diagnosis of dementia.

Methods

One hundred twenty subjects with clinical follow-up of at least 1 year with two scans were selected from a cognitive disorders clinic. Scans were reviewed as a single first scan (method A), two unregistered scans presented side-by-side (method B) and a registered pair (method C). Scans were presented to two neuroradiologists and a clinician together with approximate scan interval (if applicable) and age. Raters decided on a main and subtype diagnosis.

Results

There was no evidence that differences between methods (expressed as relative odds of a correct response) differed between reviewers (p = 0.17 for degenerative condition or not, p = 0.5 for main diagnosis, p = 0.16 for subtype). Accordingly, results were pooled over reviewers. For distinguishing normal/non-progressors from degenerative conditions, the proportions correctly diagnosed were higher with methods B and C than with A (p = 0.001, both tests). The difference between method B and C was not statistically significant (p = 0.18). For main diagnosis, the proportion of correct diagnoses were highest with method C for all three reviewers; however, this was not statistically significant comparing with method A (p = 0.23) or with method B (p = 0.16). For subtype diagnosis, there was some evidence that method C was better than method A (p = 0.01) and B (p = 0.048).

Conclusions

Serial MRI and registration may improve visual diagnosis in dementia.
Literatur
1.
Zurück zum Zitat Ferri CP, Prince M, Brayne C, Brodaty H, Fratiglioni L, Ganguli M, Hall K, Hasegawa K, Hendrie H, Huang Y, Jorm A, Mathers C, Menezes PR, Rimmer E, Scazufca M (2005) Global prevalence of dementia: a Delphi consensus study. Lancet 366:2112–2117CrossRefPubMed Ferri CP, Prince M, Brayne C, Brodaty H, Fratiglioni L, Ganguli M, Hall K, Hasegawa K, Hendrie H, Huang Y, Jorm A, Mathers C, Menezes PR, Rimmer E, Scazufca M (2005) Global prevalence of dementia: a Delphi consensus study. Lancet 366:2112–2117CrossRefPubMed
2.
Zurück zum Zitat Jellinger KA (2006) Clinicopathological analysis of dementia disorders in the elderly—an update. J Alzheimers Dis 9:61–70PubMed Jellinger KA (2006) Clinicopathological analysis of dementia disorders in the elderly—an update. J Alzheimers Dis 9:61–70PubMed
3.
Zurück zum Zitat Barker WW, Luis CA, Kashuba A, Luis M, Harwood DG, Loewenstein D, Waters C, Jimison P, Shepherd E, Sevush S, Graff-Radford N, Newland D, Todd M, Miller B, Gold M, Heilman K, Doty L, Goodman I, Robinson B, Pearl G, Dickson D, Duara R (2002) Relative frequencies of Alzheimer disease, Lewy body, vascular and frontotemporal dementia, and hippocampal sclerosis in the State of Florida Brain Bank. Alzheimer Dis Assoc Disord 16:203–212CrossRefPubMed Barker WW, Luis CA, Kashuba A, Luis M, Harwood DG, Loewenstein D, Waters C, Jimison P, Shepherd E, Sevush S, Graff-Radford N, Newland D, Todd M, Miller B, Gold M, Heilman K, Doty L, Goodman I, Robinson B, Pearl G, Dickson D, Duara R (2002) Relative frequencies of Alzheimer disease, Lewy body, vascular and frontotemporal dementia, and hippocampal sclerosis in the State of Florida Brain Bank. Alzheimer Dis Assoc Disord 16:203–212CrossRefPubMed
4.
Zurück zum Zitat Ratnavalli E, Brayne C, Dawson K, Hodges JR (2002) The prevalence of frontotemporal dementia. Neurol 58:1615–1621 Ratnavalli E, Brayne C, Dawson K, Hodges JR (2002) The prevalence of frontotemporal dementia. Neurol 58:1615–1621
5.
Zurück zum Zitat Braak H, Braak E (1991) Neuropathological staging of Alzheimer-related changes. Acta Neuropathol 82:239–259CrossRefPubMed Braak H, Braak E (1991) Neuropathological staging of Alzheimer-related changes. Acta Neuropathol 82:239–259CrossRefPubMed
6.
Zurück zum Zitat Galton CJ, Patterson K, Xuereb JH, Hodges JR (2000) Atypical and typical presentations of Alzheimer’s disease: a clinical, neuropsychological, neuroimaging and pathological study of 13 cases. Brain 123:484–498CrossRefPubMed Galton CJ, Patterson K, Xuereb JH, Hodges JR (2000) Atypical and typical presentations of Alzheimer’s disease: a clinical, neuropsychological, neuroimaging and pathological study of 13 cases. Brain 123:484–498CrossRefPubMed
7.
Zurück zum Zitat Mackenzie IRA, Rademakers R (2007) The molecular genetics and neuropathology of frontotemporal lobar degeneration: recent developments. Neurogenetics 8:237–248CrossRefPubMed Mackenzie IRA, Rademakers R (2007) The molecular genetics and neuropathology of frontotemporal lobar degeneration: recent developments. Neurogenetics 8:237–248CrossRefPubMed
8.
9.
Zurück zum Zitat Dubois B, Feldman HH, Jacova C, DeKosky ST, Barberger-Gateau P, Cummings J, Delacourte A, Galasko D, Gauthier S, Jicha G, Meguro K, O’Brien J, Pasquier F, Robert P, Rossor M, Salloway S, Stern Y, Visser PJ, Scheltens P (2007) Research criteria for the diagnosis of Alzheimer’s disease: revising the NINCDS-ADRDA criteria. Lancet Neurol 6:734–746CrossRefPubMed Dubois B, Feldman HH, Jacova C, DeKosky ST, Barberger-Gateau P, Cummings J, Delacourte A, Galasko D, Gauthier S, Jicha G, Meguro K, O’Brien J, Pasquier F, Robert P, Rossor M, Salloway S, Stern Y, Visser PJ, Scheltens P (2007) Research criteria for the diagnosis of Alzheimer’s disease: revising the NINCDS-ADRDA criteria. Lancet Neurol 6:734–746CrossRefPubMed
10.
Zurück zum Zitat Neary D, Snowden JS, Gustafson L, Passant U, Stuss D, Black S, Freedman M, Kertesz A, Robert PH, Albert M, Boone K, Miller BL, Cummings J, Benson DF (1998) Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurol 51:1546–1554 Neary D, Snowden JS, Gustafson L, Passant U, Stuss D, Black S, Freedman M, Kertesz A, Robert PH, Albert M, Boone K, Miller BL, Cummings J, Benson DF (1998) Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurol 51:1546–1554
11.
Zurück zum Zitat Fox NC, Freeborough PA (1997) Brain atrophy progression measured from registered serial MRI: validation and application to Alzheimer’s disease. J Magn Reson Imaging 7:1069–1075CrossRefPubMed Fox NC, Freeborough PA (1997) Brain atrophy progression measured from registered serial MRI: validation and application to Alzheimer’s disease. J Magn Reson Imaging 7:1069–1075CrossRefPubMed
12.
Zurück zum Zitat Smith SM, Zhang YY, Jenkinson M, Chen J, Matthews PM, Federico A, De Stefano N (2002) Accurate, robust, and automated longitudinal and cross-sectional brain change analysis. Neuroimage 17:479–489CrossRefPubMed Smith SM, Zhang YY, Jenkinson M, Chen J, Matthews PM, Federico A, De Stefano N (2002) Accurate, robust, and automated longitudinal and cross-sectional brain change analysis. Neuroimage 17:479–489CrossRefPubMed
13.
Zurück zum Zitat Freeborough PA, Fox NC (1997) The boundary shift integral: an accurate and robust measure of cerebral volume changes from registered repeat MRI. IEEE Trans Med Imaging 16:623–629CrossRefPubMed Freeborough PA, Fox NC (1997) The boundary shift integral: an accurate and robust measure of cerebral volume changes from registered repeat MRI. IEEE Trans Med Imaging 16:623–629CrossRefPubMed
14.
Zurück zum Zitat Fox NC, Crum WR, Scahill RI, Stevens JM, Janssen JC, Rossor MN (2001) Imaging of onset and progression of Alzheimer’s disease with voxel-compression mapping of serial magnetic resonance images. Lancet 358:201–205CrossRefPubMed Fox NC, Crum WR, Scahill RI, Stevens JM, Janssen JC, Rossor MN (2001) Imaging of onset and progression of Alzheimer’s disease with voxel-compression mapping of serial magnetic resonance images. Lancet 358:201–205CrossRefPubMed
15.
Zurück zum Zitat Scahill RI, Schott JM, Stevens JM, Rossor MN, Fox NC (2002) Mapping the evolution of regional atrophy in Alzheimer’s disease: unbiased analysis of fluid-registered serial MRI. Proc Nat Acad Sci (USA) 99:4703–4707CrossRef Scahill RI, Schott JM, Stevens JM, Rossor MN, Fox NC (2002) Mapping the evolution of regional atrophy in Alzheimer’s disease: unbiased analysis of fluid-registered serial MRI. Proc Nat Acad Sci (USA) 99:4703–4707CrossRef
16.
Zurück zum Zitat Barnes J, Scahill RI, Boyes RG, Frost C, Lewis EB, Rossor CL, Rossor MN, Fox NC (2004) Differentiating AD from aging using semiautomated measurement of hippocampal atrophy rates. Neuroimage 23:574–581CrossRefPubMed Barnes J, Scahill RI, Boyes RG, Frost C, Lewis EB, Rossor CL, Rossor MN, Fox NC (2004) Differentiating AD from aging using semiautomated measurement of hippocampal atrophy rates. Neuroimage 23:574–581CrossRefPubMed
17.
Zurück zum Zitat Jack CR Jr, Shiung MM, Weigand SD, O’Brien PC, Gunter JL, Boeve BF, Knopman DS, Smith GE, Ivnik RJ, Tangalos EG, Petersen RC (2005) Brain atrophy rates predict subsequent clinical conversion in normal elderly and amnestic MCI. Neurol 65:1227–1231CrossRef Jack CR Jr, Shiung MM, Weigand SD, O’Brien PC, Gunter JL, Boeve BF, Knopman DS, Smith GE, Ivnik RJ, Tangalos EG, Petersen RC (2005) Brain atrophy rates predict subsequent clinical conversion in normal elderly and amnestic MCI. Neurol 65:1227–1231CrossRef
18.
Zurück zum Zitat McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease. Neurol 34:939–944 McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease. Neurol 34:939–944
19.
Zurück zum Zitat Barnes J, Godbolt AK, Frost C, Boyes RG, Jones BF, Scahill RI, Rossor MN, Fox NC (2007) Atrophy rates of the cingulate gyrus and hippocampus in AD and FTLD. Neurobiol Aging 28:20–28CrossRefPubMed Barnes J, Godbolt AK, Frost C, Boyes RG, Jones BF, Scahill RI, Rossor MN, Fox NC (2007) Atrophy rates of the cingulate gyrus and hippocampus in AD and FTLD. Neurobiol Aging 28:20–28CrossRefPubMed
20.
Zurück zum Zitat Kloppel S, Stonnington CM, Barnes J, Chen F, Chu C, Good CD, Mader I, Mitchell LA, Patel AC, Roberts CC, Fox NC, Jack CR Jr, Ashburner J, Frackowiak RS (2008) Accuracy of dementia diagnosis: a direct comparison between radiologists and a computerized method. Brain 131:2969–2974CrossRefPubMed Kloppel S, Stonnington CM, Barnes J, Chen F, Chu C, Good CD, Mader I, Mitchell LA, Patel AC, Roberts CC, Fox NC, Jack CR Jr, Ashburner J, Frackowiak RS (2008) Accuracy of dementia diagnosis: a direct comparison between radiologists and a computerized method. Brain 131:2969–2974CrossRefPubMed
21.
Zurück zum Zitat Kloppel S, Stonnington CM, Chu C, Draganski B, Scahill RI, Rohrer JD, Fox NC, Jack CR Jr, Ashburner J, Frackowiak RS (2008) Automatic classification of MR scans in Alzheimer’s disease. Brain 131:681–689CrossRefPubMed Kloppel S, Stonnington CM, Chu C, Draganski B, Scahill RI, Rohrer JD, Fox NC, Jack CR Jr, Ashburner J, Frackowiak RS (2008) Automatic classification of MR scans in Alzheimer’s disease. Brain 131:681–689CrossRefPubMed
22.
Zurück zum Zitat Woods RP, Grafton ST, Holmes CJ, Cherry SR, Mazziotta JC (1998) Automated image registration: I. General methods and intrasubject, intramodality validation. J Comput Assist Tomogr 22:139–152CrossRefPubMed Woods RP, Grafton ST, Holmes CJ, Cherry SR, Mazziotta JC (1998) Automated image registration: I. General methods and intrasubject, intramodality validation. J Comput Assist Tomogr 22:139–152CrossRefPubMed
23.
Zurück zum Zitat Lewis EB, Fox NC (2004) Correction of differential intensity inhomogeneity in longitudinal MR images. Neuroimage 23:75–83CrossRefPubMed Lewis EB, Fox NC (2004) Correction of differential intensity inhomogeneity in longitudinal MR images. Neuroimage 23:75–83CrossRefPubMed
24.
Zurück zum Zitat Jones B, Kenward MG (2003) Design and analysis of cross-over trials, 2nd edn. Chapman and Hall, London Jones B, Kenward MG (2003) Design and analysis of cross-over trials, 2nd edn. Chapman and Hall, London
25.
Zurück zum Zitat Senn S (2002) Cross-over trials in clinical research, 2nd edn. Wiley, Chichester Senn S (2002) Cross-over trials in clinical research, 2nd edn. Wiley, Chichester
26.
Zurück zum Zitat Freeborough PA, Fox NC, Kitney RI (1997) Interactive algorithms for the segmentation and quantitation of 3-D MRI brain scans. Comput Methods Programs Biomed 53:15–25CrossRefPubMed Freeborough PA, Fox NC, Kitney RI (1997) Interactive algorithms for the segmentation and quantitation of 3-D MRI brain scans. Comput Methods Programs Biomed 53:15–25CrossRefPubMed
27.
Zurück zum Zitat Yoo TS, Ackerman MJ, Lorensen WE, Schroeder W, Chalana V, Aylward S, Metaxes D, Whitaker R (2002) Engineering and algorithm design for an image processing API: a technical report on ITK—the insight toolkit. IOS Press, Amsterdam, pp 586–592 Yoo TS, Ackerman MJ, Lorensen WE, Schroeder W, Chalana V, Aylward S, Metaxes D, Whitaker R (2002) Engineering and algorithm design for an image processing API: a technical report on ITK—the insight toolkit. IOS Press, Amsterdam, pp 586–592
28.
Zurück zum Zitat Collins DL, Neelin P, Peters TM, Evans AC (1994) Automatic 3D intersubject registration of MR volumetric data in standardized Talairach space. J Comput Assist Tomogr 18:192–205CrossRefPubMed Collins DL, Neelin P, Peters TM, Evans AC (1994) Automatic 3D intersubject registration of MR volumetric data in standardized Talairach space. J Comput Assist Tomogr 18:192–205CrossRefPubMed
29.
Zurück zum Zitat Papademetris X, Jackowski N, Rajeevan N, Constable RT, Staib LH. BioImage Suite: an integrated medical image analysis suite, Section of Bioimaging Sciences, Dept. of Diagnostic Radiology, Yale School of Medicine. http://www.bioimagesuite.org Papademetris X, Jackowski N, Rajeevan N, Constable RT, Staib LH. BioImage Suite: an integrated medical image analysis suite, Section of Bioimaging Sciences, Dept. of Diagnostic Radiology, Yale School of Medicine. http://​www.​bioimagesuite.​org
30.
Zurück zum Zitat Studholme C, Hill DLG, Hawkes DJ (1999) An overlap invariant entropy measure of 3D medical image alignment. Pattern Recogn 32:71–86CrossRef Studholme C, Hill DLG, Hawkes DJ (1999) An overlap invariant entropy measure of 3D medical image alignment. Pattern Recogn 32:71–86CrossRef
31.
Zurück zum Zitat Scheltens P, Leys D, Barkhof F, Huglo D, Weinstein HC, Vermersch P, Kuiper M, Steinling M, Wolters EC, Valk J (1992) Atrophy of medial temporal lobes on MRI in ‘probable’ Alzheimer’s disease and normal ageing: diagnostic value and neuropsychological correlates. J Neurol Neurosurg Psychiatry 55(10):967–972CrossRefPubMed Scheltens P, Leys D, Barkhof F, Huglo D, Weinstein HC, Vermersch P, Kuiper M, Steinling M, Wolters EC, Valk J (1992) Atrophy of medial temporal lobes on MRI in ‘probable’ Alzheimer’s disease and normal ageing: diagnostic value and neuropsychological correlates. J Neurol Neurosurg Psychiatry 55(10):967–972CrossRefPubMed
32.
Zurück zum Zitat Bresciani L, Rossi R, Testa C, Geroldi C, Galluzzi S, Laakso MP, Beltramello A, Soininen H, Frisoni GB (2005) Visual assessment of medial temporal atrophy on MR films in Alzheimer’s disease: comparison with volumetry. Aging Clin Exp Res 17:8–13PubMed Bresciani L, Rossi R, Testa C, Geroldi C, Galluzzi S, Laakso MP, Beltramello A, Soininen H, Frisoni GB (2005) Visual assessment of medial temporal atrophy on MR films in Alzheimer’s disease: comparison with volumetry. Aging Clin Exp Res 17:8–13PubMed
33.
Zurück zum Zitat Gao FQ, Black SE, Leibovitch FS, Callen DJ, Rockel CP, Szalai JP (2004) Linear width of the medial temporal lobe can discriminate Alzheimer’s disease from normal aging: the Sunnybrook dementia study. Neurobiol Aging 25:441–448CrossRefPubMed Gao FQ, Black SE, Leibovitch FS, Callen DJ, Rockel CP, Szalai JP (2004) Linear width of the medial temporal lobe can discriminate Alzheimer’s disease from normal aging: the Sunnybrook dementia study. Neurobiol Aging 25:441–448CrossRefPubMed
34.
Zurück zum Zitat Davies RR, Scahill VL, Graham A, Williams GB, Graham KS, Hodges JR (2009) Development of an MRI rating scale for multiple brain regions: comparison with volumetrics and with voxel-based morphometry. Neuroradiology 51:491–503CrossRefPubMed Davies RR, Scahill VL, Graham A, Williams GB, Graham KS, Hodges JR (2009) Development of an MRI rating scale for multiple brain regions: comparison with volumetrics and with voxel-based morphometry. Neuroradiology 51:491–503CrossRefPubMed
35.
Zurück zum Zitat Jack CR Jr, Petersen RC, O’Brien PC, Tangalos EG (1992) MR-based hippocampal volumetry in the diagnosis of Alzheimer’s disease. Neurol 42:183–188 Jack CR Jr, Petersen RC, O’Brien PC, Tangalos EG (1992) MR-based hippocampal volumetry in the diagnosis of Alzheimer’s disease. Neurol 42:183–188
36.
Zurück zum Zitat Chan D, Fox NC, Scahill RI, Crum WR, Whitwell JL, Leschziner G, Rossor AM, Stevens JM, Cipolotti L, Rossor MN (2001) Patterns of temporal lobe atrophy in semantic dementia and Alzheimer’s disease. Ann Neurol 49:433–442CrossRefPubMed Chan D, Fox NC, Scahill RI, Crum WR, Whitwell JL, Leschziner G, Rossor AM, Stevens JM, Cipolotti L, Rossor MN (2001) Patterns of temporal lobe atrophy in semantic dementia and Alzheimer’s disease. Ann Neurol 49:433–442CrossRefPubMed
37.
Zurück zum Zitat Barnes J, Whitwell JL, Frost C, Josephs KA, Rossor M, Fox NC (2006) Measurements of the amygdala and hippocampus in pathologically confirmed Alzheimer disease and frontotemporal lobar degeneration. Arch Neurol 63:1434–1439CrossRefPubMed Barnes J, Whitwell JL, Frost C, Josephs KA, Rossor M, Fox NC (2006) Measurements of the amygdala and hippocampus in pathologically confirmed Alzheimer disease and frontotemporal lobar degeneration. Arch Neurol 63:1434–1439CrossRefPubMed
38.
Zurück zum Zitat Lerch JP, Pruessner J, Zijdenbos AP, Collins DL, Teipel SJ, Hampel H, Evans AC (2008) Automated cortical thickness measurements from MRI can accurately separate Alzheimer’s patients from normal elderly controls. Neurobiol Aging 29:23–30CrossRefPubMed Lerch JP, Pruessner J, Zijdenbos AP, Collins DL, Teipel SJ, Hampel H, Evans AC (2008) Automated cortical thickness measurements from MRI can accurately separate Alzheimer’s patients from normal elderly controls. Neurobiol Aging 29:23–30CrossRefPubMed
39.
Zurück zum Zitat Wald NJ, Murphy P, Major P, Parkes C, Townsend J, Frost C (1995) UKCCCR multicentre randomised controlled trial of one and two view mammography in breast cancer screening. BMJ 311:1189–1193PubMed Wald NJ, Murphy P, Major P, Parkes C, Townsend J, Frost C (1995) UKCCCR multicentre randomised controlled trial of one and two view mammography in breast cancer screening. BMJ 311:1189–1193PubMed
Metadaten
Titel
Does registration of serial MRI improve diagnosis of dementia?
verfasst von
Josephine Barnes
L. Anne Mitchell
Jonathan Kennedy
Antonio J. Bastos-Leite
Suzie Barker
Manja Lehmann
R. Chris Nordstrom
Chris Frost
Joseph R. Smith
Ellen Garde
Martin N. Rossor
Nick C. Fox
Publikationsdatum
01.11.2010
Verlag
Springer-Verlag
Erschienen in
Neuroradiology / Ausgabe 11/2010
Print ISSN: 0028-3940
Elektronische ISSN: 1432-1920
DOI
https://doi.org/10.1007/s00234-010-0665-x

Weitere Artikel der Ausgabe 11/2010

Neuroradiology 11/2010 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.